Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.

Ignacio Relaño-RodríguezRaquel Juárez-SánchezCarolina PavicicEduardo MuñozMaria Angeles Muñoz-Fernández

Published in: Journal of nanobiotechnology (2019)

We showed for the first time that nanoparticles, in this case, G3-S16 anionic carbosilan dendrimer may play an important role in new treatments against HIV-1 infection.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
early stage
hepatitis c virus
hiv aids
hiv testing
men who have sex with men
combination therapy